5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT)a metabolic regulator tied to fat storage, NAD depletion, and reduced energy expenditure
Eli Lilly reported these results in mid-2025, and the retatrutide availability timeline now points toward potential FDA approval no earlier than 2027, as additional phase 3 trials continue
Swiss Chems Disclaimer: Peptides.org contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated
This keeps the math identical to every other vial size using the base-10 approach, where each 10 units equals 1mg
Continue reading to learn more about the documented benefits of these popular research peptides, as well as proper handling, safety, and sourcing